PASITHEA THERAPEUTICS CORP. Exchange Rate Effect on Cash
PASITHEA THERAPEUTICS CORP. (KTTA) reported Exchange Rate Effect on Cash of -$620 for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations · last filed 2024-05-14
- PASITHEA THERAPEUTICS CORP. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for the quarter ending 2024-03-31 was -$620.00.
- PASITHEA THERAPEUTICS CORP. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for the quarter ending 2023-03-31 was -$2.48K.
- PASITHEA THERAPEUTICS CORP. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for the quarter ending 2022-03-31 was -$4.51K.
- PASITHEA THERAPEUTICS CORP. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for fiscal 2023 was -$3.99K, a 140.31% decline from fiscal 2022.
- PASITHEA THERAPEUTICS CORP. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for fiscal 2022 was $9.90K.
- PASITHEA THERAPEUTICS CORP. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for fiscal 2021 was -$10.56K.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations 3 month as first filed | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations 12 month |
|---|---|---|---|---|---|
| 2024-03-31 | -$620.00 10-Q · filed 2024-05-14 | ||||
| 2023-12-31 | -$3.99K 10-K · filed 2024-03-29 | ||||
| 2023-06-30 | -$2.80K 10-Q · filed 2023-08-11 | ||||
| 2023-03-31 | -$2.48K 10-Q · filed 2024-05-14 | ||||
| 2022-12-31 | $9.90K 10-K · filed 2024-03-29 | ||||
| 2022-09-30 | -$119.70K 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | -$47.01K 10-Q · filed 2023-08-11 | ||||
| 2022-03-31 | -$4.51K 10-Q · filed 2023-05-12 | -$4.16K 10-Q · filed 2022-05-16 | |||
| 2021-12-31 | -$10.56K 10-K · filed 2022-03-30 | ||||
| 2021-09-30 | -$3.76K 10-Q · filed 2022-11-14 | ||||
| 2021-06-30 | -$2.31K 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |